CANCER DIAGNOSIS USING OPTIMAL CLUSTERING WITH SUCCESSIVE DECONVOLUTION

    公开(公告)号:US20210217526A1

    公开(公告)日:2021-07-15

    申请号:US17145385

    申请日:2021-01-10

    Abstract: An apparatus and/or method that includes deconvolving a pre-deconvoluted distribution of spectrometry reference profile peaks into at least two post-deconvoluted distributions of spectrometry reference profile peaks. Through this deconvolution, sufficiently narrow probability distribution functions may be attained, which may contribute to diagnostic accuracy. The pre-convoluted distribution of spectrometry reference profile peaks originated from spectrometry reference profiles associated with a first category. The at least two post-deconvoluted distributions of spectrometry reference profile peaks each originated from spectrometry reference profiles each associated with at least two different sub-categories of the first category. For example, the first category may be cancer in general and the at least two sub-categories may be types of cancer. These different types of cancer may be further deconvolved into more subcategories to form a cluster of probability distribution functions, which are meaningful in diagnostic applications.

    ANTIMICROBIAL SUSCEPTIBILITY TESTING USING LIBRARY MATCH

    公开(公告)号:US20200286592A1

    公开(公告)日:2020-09-10

    申请号:US16810840

    申请日:2020-03-06

    Inventor: Eung Joon Jo

    Abstract: A method, apparatus, and/or computer program product that matches a treatment profile (e.g. drug treatment at a particular dosage and timeframe) to a sample of biological material (e.g. blood sample, etc.). A mass spectrometry spectrum may be generated from a matrix-assisted laser desorption ionization time of flight mass spectrometer (MALDI-TOF MS) device from the testing of a sample of biological material that includes at least one pathogen (e.g. bacteria, microorganism, virus, etc.). This received mass spectrometry spectrum may be matched by a diagnostic unit to determine the species of the pathogen against a species database. The species database may include predetermined mass spectrometry spectrums of known species of pathogens. Based on the matched species of pathogen, a diagnostic unit may match the received mass spectrometry spectrum of the sample of biological material to at least one treatment profile from a second reference database of predetermined mass spectrometry spectrums.

Patent Agency Ranking